ArticleACS omega2026
Modeling the Removal of Hexavalent Chromium from Aqueous Solution Using a Pyridinium-Based Poly(ionic liquid).
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chromium-(VI) is a highly toxic pollutant commonly found in industrial wastewater, requiring effective removal strategies. While various remediation technologies exist, many suffer limitations from high costs, energy demands, or inefficiency. Adsorption has emerged as a particularly promising alternative due to its low cost, operational simplicity, and wide range of applicable materials. Recently, focus has turned toward poly-(ionic liquids) (PILs), a class of versatile hybrid materials that combine the advantageous properties of polymers and ionic liquids, including thermal stability, low volatility, and diverse interaction capabilities with target pollutants. In this work, a pyridinium-based PIL containing BF
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.